ZXH-4-130 is primarily utilized in the field of medicinal chemistry and drug development. It functions as a potent inhibitor targeting specific protein kinases, which play a critical role in cellular signaling pathways. This makes it a valuable tool in researching and treating diseases such as cancer, where dysregulated kinase activity is often a contributing factor. Researchers use ZXH-4-130 to study the mechanisms of kinase inhibition and to develop targeted therapies that can selectively block aberrant signaling in cancer cells. Additionally, it has shown promise in preclinical studies for its potential to enhance the efficacy of existing treatments when used in combination therapies. Its application extends to the development of novel therapeutic agents aimed at improving patient outcomes in oncology.